{
    "symbol": "INM",
    "quarter": 2,
    "year": 2022,
    "date": "2022-02-15 20:18:04",
    "content": "   At this time, I would like to welcome everyone to InMed's Second Quarter Fiscal 2022 Financial Results and Business Update Conference Call for the period ended December 31, 2021. from a commercial perspective, our primary goals for the BayMedica business over the next few quarters include launching new products to build a robust product portfolio of rare cannabinoids, increase revenues and margins from new and existing products through B2B sales, enhance the sales and marketing infrastructure to support anticipated growth, improve margins through the technical improvements and scale up efficiencies, develop new cannabinoid analogues for potential lead molecule identification for pharmaceutical applications."
}